4
Changes in Ownership
PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-052248
SVP, Regulatory Affairs and QA sold 2,896 shares at $33.78 ($97,814)
- SVP, Regulatory Affairs and QA acquired 2,896 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Jalota Deepika · SVP, Regulatory Affairs and QA
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-17 | Exercise or conversion : show line 1 in the form | +2,896 | $3.53 | $10,223 | 2,896 | D |
| 2021-08-17 | Sale : show line 2 in the form | −2,896 | $33.78 | $97,814 | 0 | D |
| Open-market sales · 2,896 sh · avg $33.78 · $97,814 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-17 | Exercise or conversion : show line 3 in the form Stock option (right to buy) | −2,896 | 87,320 | D |
Loading xslF345X03/doc4.xml…